121 related articles for article (PubMed ID: 7699622)
1. The beneficial effect of the estrogen antagonist, tamoxifen, on experimental systemic lupus erythematosus.
Sthoeger ZM; Bentwich Z; Zinger H; Mozes E
J Rheumatol; 1994 Dec; 21(12):2231-8. PubMed ID: 7699622
[TBL] [Abstract][Full Text] [Related]
2. The role of the idiotypic network in the induction of experimental systemic lupus erythematosus.
Mozes E; Brocke S; Shoenfeld Y; Mendlovic S
J Cell Biochem; 1989 Jun; 40(2):173-81. PubMed ID: 2788655
[TBL] [Abstract][Full Text] [Related]
3. Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells.
Levite M; Zinger H; Mozes E; Reisner Y
Bone Marrow Transplant; 1993 Sep; 12(3):179-83. PubMed ID: 8241973
[TBL] [Abstract][Full Text] [Related]
4. The role of anti-idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice.
Mendlovic S; Fricke H; Shoenfeld Y; Mozes E
Eur J Immunol; 1989 Apr; 19(4):729-34. PubMed ID: 2659371
[TBL] [Abstract][Full Text] [Related]
5. Cytokine manipulation by methotrexate treatment in murine experimental systemic lupus erythematosus.
Dayan M; Segal R; Mozes E
J Rheumatol; 1997 Jun; 24(6):1075-82. PubMed ID: 9195512
[TBL] [Abstract][Full Text] [Related]
6. The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations.
Dayan M; Zinger H; Kalush F; Mor G; Amir-Zaltzman Y; Kohen F; Sthoeger Z; Mozes E
Immunology; 1997 Jan; 90(1):101-8. PubMed ID: 9038719
[TBL] [Abstract][Full Text] [Related]
7. Sex hormone involvement in the induction of experimental systemic lupus erythematosus by a pathogenic anti-DNA idiotype in naive mice.
Blank M; Mendlovic S; Fricke H; Mozes E; Talal N; Shoenfeld Y
J Rheumatol; 1990 Mar; 17(3):311-7. PubMed ID: 2332851
[TBL] [Abstract][Full Text] [Related]
8. Induction of lupus-associated autoantibodies by immunization with native and recombinant Ig polypeptides expressing a cross-reactive idiotype 4B4.
Dang H; Ogawa N; Takei M; Lazaridis K; Talal N
J Immunol; 1993 Dec; 151(12):7260-7. PubMed ID: 8258723
[TBL] [Abstract][Full Text] [Related]
9. Idiotype specific T-cell lines inducing experimental systemic lupus erythematosus in mice.
Fricke H; Mendlovic S; Blank M; Shoenfeld Y; Ben-Bassat M; Mozes E
Immunology; 1991 Aug; 73(4):421-7. PubMed ID: 1916893
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus.
Levite M; Zinger H; Zisman E; Reisner Y; Mozes E
Cell Immunol; 1995 Apr; 162(1):138-45. PubMed ID: 7704902
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies.
Sthoeger ZM; Zinger H; Mozes E
Ann Rheum Dis; 2003 Apr; 62(4):341-6. PubMed ID: 12634234
[TBL] [Abstract][Full Text] [Related]
12. The genetic regulation of the induction of experimental SLE.
Mendlovic S; Brocke S; Fricke H; Shoenfeld Y; Bakimer R; Mozes E
Immunology; 1990 Feb; 69(2):228-36. PubMed ID: 2307482
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease.
Segal R; Bermas BL; Dayan M; Kalush F; Shearer GM; Mozes E
J Immunol; 1997 Mar; 158(6):3009-16. PubMed ID: 9058840
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of diabetes in NOD mice by idiotypic induction of SLE.
Krause I; Tomer Y; Elias D; Blank M; Gilburd B; Cohen IR; Shoenfeld Y
J Autoimmun; 1999 Aug; 13(1):49-55. PubMed ID: 10441167
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin.
Krause I; Blank M; Kopolovic J; Afek A; Goldberg I; Tomer Y; Shoenfeld Y
J Rheumatol; 1995 Jun; 22(6):1068-74. PubMed ID: 7545755
[TBL] [Abstract][Full Text] [Related]
17. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients.
Mauermann N; Sthoeger Z; Zinger H; Mozes E
Clin Exp Immunol; 2004 Sep; 137(3):513-20. PubMed ID: 15320900
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of anti-idiotypic antibodies to anti-DNA antibodies in humans.
Muryoi T; Sasaki T; Harata N; Takai O; Tamate E; Yoshinaga K
Clin Exp Immunol; 1988 Jan; 71(1):67-72. PubMed ID: 3258206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]